SCHEMBL7682672

SCHEMBL7682672

COCC1=NN=C(c2ccc(C(=O)O)nc2)[N]1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
MAPK1 P28482 1/20 0.43
P4HTM Q9NXG6 9/20 0.40
P4HA1 P13674 1/20 0.39
MIF P14174 1/20 0.39
ALDH1A1 P00352 2/20 0.38
MEN1 O00255 1/20 0.38
LMNA P02545 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
MAPT P10636 1/20 0.38
PKM P14618 1/20 0.38
ALOX15 P16050 1/20 0.38
TSHR P16473 1/20 0.38
NFKB1 P19838 1/20 0.38
THPO P40225 1/20 0.38
BLM P54132 1/20 0.38
PMP22 Q01453 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7675159 0.80 HPGDS (0.35) PKM
SCHEMBL2631698 0.72 P4HTM (0.61) KDM4EL3MBTL1MAPK1P4HTMP4HA1
SCHEMBL13731115 0.71 P4HTM (0.64) KDM4EL3MBTL1MAPK1P4HTMP4HA1
SCHEMBL11044314 0.67 P4HTM (0.53) KDM4EL3MBTL1MAPK1P4HTMP4HA1
SCHEMBL11040996 0.66 P4HTM (0.60) KDM4EL3MBTL1MAPK1P4HTMALDH1A1
SCHEMBL2633139 0.65 EGLN1 (0.62) KDM4EL3MBTL1MAPK1P4HTMP4HA1
SCHEMBL13466807 0.65 P4HTM (0.59) KDM4EL3MBTL1MAPK1P4HTMP4HA1
SCHEMBL9613265 0.65 ALDH1A1 (0.57) KDM4EL3MBTL1MAPK1P4HTMP4HA1
SCHEMBL11046284 0.65 PDE4A (0.57) KDM4EL3MBTL1MAPK1P4HTMALDH1A1
SCHEMBL27755250 0.65 EGLN1 (0.59) KDM4EL3MBTL1MAPK1P4HTMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6376490-B1 STRONG N-METHYL-D-ASPARATE RECEPTOR ANTAGONISTS; USEFUL IN TREATING STROKES, ISCHEMIA, AND CENTRAL NERVOUS SYSTEM INJURIES PFIZER INC 2002-04-23 US claimed
EP-0885212-B1 QUINOXALINEDIONES PFIZER RES AND BR DEV COMPANY (IE) 2001-11-14 EP claimed
JP-3110467-B2 2000-11-20 JP claimed
EP-0885212-A1 QUINOXALINEDIONES Pfizer Research and Development Company, N.V./S.A. (IE) 1998-12-23 EP claimed
WO-1997032873-A1 QUINOXALINEDIONES PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-09-12 WO claimed
US-6376490-B1 STRONG N-METHYL-D-ASPARATE RECEPTOR ANTAGONISTS; USEFUL IN TREATING STROKES, ISCHEMIA, AND CENTRAL NERVOUS SYSTEM INJURIES PFIZER INC 2002-04-23 US disclosed
EP-0885212-B1 QUINOXALINEDIONES PFIZER RES AND BR DEV COMPANY (IE) 2001-11-14 EP disclosed
EP-0885212-A1 QUINOXALINEDIONES Pfizer Research and Development Company, N.V./S.A. (IE) 1998-12-23 EP disclosed
WO-1997032873-A1 QUINOXALINEDIONES PFIZER RESEARCH AND DEVELOPMENT COMPANY, N.V./S.A. (IE) 1997-09-12 WO disclosed